About QuaDRAD
QuaDRAD is a company based in Sapporo (Japan) founded in 2010.. QuaDRAD operates in a competitive market with competitors including Adimab, Aphios, CDI Labs, Single Cell Technology and OmniAb, among others.
- Headquarter Sapporo, Japan
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of QuaDRAD
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2016 | Amount | Series A - QuaDRAD | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in QuaDRAD
QuaDRAD has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Mitsubishi UFJ Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is invested in AI, energy, and various sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by QuaDRAD
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - QuaDRAD
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Quadrad Comparisons
Competitors of QuaDRAD
QuaDRAD operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adimab, Aphios, CDI Labs, Single Cell Technology and OmniAb, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibodies are discovered and optimized for autoimmune and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Autoantibody detection and profiling products and services are provided.
|
|
| domain | founded_year | HQ Location |
Antibodies and mRNA are discovered from individual antibody-secreting cells.
|
|
| domain | founded_year | HQ Location |
Transgenic animal platforms are developed for human therapeutic antibody production.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about QuaDRAD
When was QuaDRAD founded?
QuaDRAD was founded in 2010 and raised its 1st funding round 6 years after it was founded.
Where is QuaDRAD located?
QuaDRAD is headquartered in Sapporo, Japan. It is registered at Sapporo, Hokkaido, Japan.
What does QuaDRAD do?
Medicinal chemistry pharmaceutical has designed an antibody development platform called QuaDRAD system. The technology uses glycosylated peptide approach to generate monoclonal antibodies against the antigen. Produced antibodies are then screened for their specificity to the epitope ( Epitope-Defined Antibody) by using microarray technology. The positive from the screen are further tested in animal models. Glycoproteins have been known to generate antibodies specific to the sugar moieties which enables recognition of the residue irrespective of the carrier, and it has been reported that glycopeptides are presented by MHC class 1 and II, making it a potential target for therapeutics.
Who are the top competitors of QuaDRAD?
Who are QuaDRAD's investors?
QuaDRAD has 1 investor. Key investors include Mitsubishi UFJ Capital.